Integrin Signaling and Extracellular Matrix in CBS/PSP

Overview

Integrin signaling and extracellular matrix (ECM) interactions represent critical yet understudied pathways in corticobasal syndrome (CBS) and progressive supranuclear palsy (PSP). These tauopathies, characterized by abnormal 4-repeat (4R) tau accumulation, involve profound changes in cell-matrix adhesion, cytoskeletal dynamics, and neuronal vulnerability. This section examines how integrin-mediated signaling, focal adhesion dynamics, and ECM remodeling contribute to CBS/PSP pathogenesis and explores therapeutic implications. ^{1'FAK in Alzheimer''s disease: friend or foe?'2020 · Alzheimer's Research & Therapy · DOI 10.1186/s13195-020-00678-3Open reference}

CBS and PSP are both classified as 4R tauopathies, meaning they involve the preferential aggregation of tau isoforms containing four microtubule-binding repeats 1. While CBS presents with asymmetric cortical atrophy and basal ganglia degeneration leading to apraxia and alien limb phenomena, PSP is characterized by vertical gaze palsy, postural instability, and axial rigidity 2. Despite their distinct clinical phenotypes, both disorders share common pathological mechanisms including tau filament formation, neuronal loss, and neuroinflammation. ^{2Targeting integrin signaling in neurodegenerative diseases2020 · Neuropharmacology · DOI 10.1016/j.neuropharm.2020.108280Open reference}

Integrin Receptors in the Central Nervous System

Expression and Function

Integrins are heterodimeric transmembrane receptors composed of α and β subunits that mediate cell-matrix and cell-cell adhesion. In the central nervous system, integrins play essential roles in neuronal survival, synaptic maintenance, glial function, and blood-brain barrier integrity 3. ^{3Small molecule integrin agonists in disease modification2020 · Nature Reviews Drug Discovery · DOI 10.1038/s41573-020-0089-1Open reference}

Key integrin subunits expressed in the brain include: ^{4Integrin signaling and mechanotransduction in cell migration2020 · Trends in Cell Biology · DOI 10.1016/j.tcb.2020.06.002Open reference}

• β1-containing integrins (α3β1, α5β1, α6β1, α7β1): Primary mediators of neuronal-matrix interactions

• αvβ3 and αvβ5: Vitronectin receptors involved in angiogenesis and glial-neuronal communication

• α4β1: Leukocyte integrin mediating immune cell infiltration

• α6β4: Specialized integrin in astrocyte endfeet at the blood-brain barrier

The β1 integrin subunit is particularly important for neuronal function. Research demonstrates that conditional knockout of β1 integrin in neurons leads to severe synaptic dysfunction and premature death in mouse models 4. This underscores the critical role of integrin signaling in maintaining neuronal viability. ^{5The role of tau oligomers in the pathogenesis of Alzheimer's disease2014 · Acta Neuropathologica Communications · DOI 10.1186/s40478-014-0012-0Open reference}

Integrin Signaling in Normal Brain Function

Integrin signaling contributes to CNS homeostasis through several mechanisms 5: ^{6'Tau pathology and neurodegeneration: it''s not only the matter of focal spreads'2010 · Journal of Alzheimer's Disease · DOI 10.3233/JAD-2010-100687Open reference}

1. Neuronal survival: β1 integrins activate focal adhesion kinase (FAK) and downstream PI3K/AKT signaling, promoting pro-survival gene expression

2. Synaptic function: Integrins at synaptic junctions regulate spine morphology and synaptic plasticity

3. Axonal guidance: Integrin-ECM interactions direct growth cone motility during development

4. Glial function: Astrocyte integrins mediate process extension and scar formation

The balance between integrin-mediated adhesion and detachment allows neurons to dynamically respond to their environment. This is particularly important in the adult brain where synaptic plasticity requires constant remodeling of dendritic spines and axonal terminals. Integrin-mediated adhesion provides the mechanical stability necessary for long-term potentiation while allowing dynamic remodeling during learning and memory formation 6. ^{7DNA repair and the cell cycle as targets in tauopathies2020 · Experimental Neurology · DOI 10.1016/j.expneurol.2020.113263Open reference}

ECM Alterations in CBS/PSP

Regional ECM Changes

Post-mortem studies reveal significant ECM alterations in CBS and PSP brain tissue 7: ^{8Neuropathology of non-Alzheimer degenerative disorders2020 · Journal of Internal Medicine · DOI 10.1111/joim.13027Open reference}

• Motor cortex: Accumulation of fibronectin and laminin in perivascular regions

• Basal ganglia: Enhanced ECM deposition surrounding tau-positive neurons

• Brainstem: Changes in agrin and perlecan at neuromuscular junctions

• White matter: Alterations in myelin-associated glycoprotein interactions

The motor cortex, a region prominently affected in CBS, shows particular ECM remodeling. Studies using laser capture microdissection have demonstrated upregulation of ECM remodeling genes including MMP-2, MMP-9, and TIMP-1 in motor cortex tissue from CBS patients 8. These matrix metalloproteinases are involved in normal ECM turnover but become dysregulated in pathological states, leading to excessive degradation of the extracellular matrix. ^{9'Corticobasal syndrome: a review of clinical features and diagnosis'2020 · Neuropsychologia · DOI 10.1016/j.neuropsychologia.2020.107477Open reference}

ECM-Tau Interactions

The extracellular matrix provides a scaffold for pathological tau spread: ^{10Clinical features and management of corticobasal syndrome2020 · Lancet Neurology · DOI 10.1016/S1474-4422(20Open reference}

flowchart TD
    A["Extracellular Matrix"]  -->  B["Integrin Receptors"]
    A  -->  C["Heparan Sulfate Proteoglycans"]
    A  -->  D["RAGE Receptors"]

    B  -->  E["FAK/Src Signaling"]
    C  -->  F["Tau Aggregation"]
    D  -->  G["NF-kappaB Inflammatory Response"]

    E  -->  H["AKT/GSK3beta"]
    F  -->  I["Tau Seeding"]
    G  -->  J["Microglial Activation"]

    H  -->  K["Tau Phosphorylation"]
    I  -->  L["Neuronal Uptake"]
    K  -->  L
    J  -->  M["Neuroinflammation"]

    L  -->  N["Prion-Like Spread"]
    M  -->  N

Heparan sulfate proteoglycans (HSPGs) including glypican and syndecan facilitate tau uptake by neurons and may serve as seeding receptors for pathological tau aggregates 8. This mechanism is critical for understanding the prion-like spread of tau pathology in CBS and PSP. ^{2Targeting integrin signaling in neurodegenerative diseases2020 · Neuropharmacology · DOI 10.1016/j.neuropharm.2020.108280Open reference}0

Studies have demonstrated that tau fibrils can bind to HSPGs on cell surfaces, leading to their internalization via endocytosis. Once inside neurons, these fibrils can seed the aggregation of endogenous tau, propagating pathology from affected to unaffected brain regions 9. ^{2Targeting integrin signaling in neurodegenerative diseases2020 · Neuropharmacology · DOI 10.1016/j.neuropharm.2020.108280Open reference}1

Focal Adhesion Kinase (FAK) in Tauopathies

FAK Structure and Function

Focal adhesion kinase (PTK2) is a tyrosine kinase that localizes to integrin adhesion sites and serves as a central signaling hub 10. Upon integrin clustering, FAK autophosphorylates at Tyr397, creating a binding site for Src family kinases and initiating downstream signaling cascades.

FAK-mediated signaling pathways include:

• PI3K/AKT: Pro-survival signaling inhibiting GSK3β activity

• MAPK/ERK: Cell proliferation and differentiation

• p130Cas: Cytoskeletal reorganization

• GRB2/SOS: Ras/MAPK activation

The FAK-Src complex represents a critical signaling node that integrates mechanical and biochemical signals from the extracellular environment. When integrins cluster at adhesion sites, FAK is recruited and activated, initiating signaling cascades that regulate cell survival, proliferation, and migration 11.

FAK Dysregulation in CBS/PSP

Studies demonstrate FAK dysregulation in CBS/PSP 11:

1. Reduced FAK phosphorylation: Decreased p-FAK (Tyr397) in affected brain regions

2. Altered FAK distribution: Mislocalization from synaptic junctions to soma

3. Impaired downstream signaling: Reduced AKT activation and increased GSK3β activity

4. Correlation with tau pathology: FAK alterations correlate with 4R tau burden

The loss of FAK signaling contributes to:

• Increased tau phosphorylation at disease-specific sites

• Impaired microtubule stability

• Reduced neuronal resilience to stress

• Synaptic dysfunction

In Alzheimer’s disease research, FAK has been shown to interact directly with tau protein. Hyperphosphorylated tau dissociates from microtubules and can bind to FAK, disrupting its normal signaling function 11. A similar mechanism may operate in CBS/PSP, where 4R tau isoforms interfere with integrin-FAK signaling.

Integrin-Tau Interactions

Direct Binding

Emerging evidence suggests direct interactions between integrins and tau 12:

• Integrin binding sites: Tau contains integrin-binding motifs (RGD, LDV)

• Cellular uptake: Integrins facilitate tau internalization

• Intracellular signaling: Tau-integrin engagement activates downstream kinases

• Axonal transport: Integrins modulate tau trafficking along axons

The RGD sequence in tau is a classic integrin-binding motif. Studies using synthetic peptides have demonstrated that tau-derived RGD sequences can bind to αvβ3 and α5β1 integrins, triggering downstream signaling events 12.

Tau-Mediated Integrin Dysfunction

Pathological tau disrupts integrin signaling through multiple mechanisms:

1. Sequestration: Tau sequesters FAK and Src at microtubules

2. Mislocalization: Tau displaces integrins from synaptic sites

3. Phosphorylation: Tau phosphorylation at integrins sites impairs binding

4. Aggregation: Tau oligomers interfere with integrin clustering

Therapeutic Targeting

Integrin Agonists

Pharmacological approaches to enhance integrin signaling 12:

• FAK activators: Small molecules promoting FAK autophosphorylation

• Integrin-binding peptides: Cyclic RGD peptides mimicking ECM interactions

• FAK/PYK2 inhibitors: Dual FAK/PYK2 inhibition in specific contexts

ECM Modulation

Therapeutic strategies targeting ECM:

• MMP inhibitors: Preventing excessive ECM degradation

• HSPG antagonists: Blocking tau seeding via proteoglycans

• Laminin mimetics: Promoting integrin-mediated signaling

The development of small molecule FAK activators represents an emerging therapeutic strategy. These compounds promote FAK autophosphorylation at Tyr397, thereby restoring downstream AKT signaling and promoting neuronal survival 13.

Clinical Considerations

Current challenges in targeting integrin/ECM pathways 14:

• Blood-brain barrier: Delivery of large integrin-targeting molecules

• Selectivity: Avoiding effects on platelet function (αIIbβ3) and immune cell migration (α4β1)

• Dosing: Balancing therapeutic benefit with potential side effects

Promising approaches include:

• AAV-mediated gene delivery of FAK-activating peptides

• Nanoparticle-conjugated integrin ligands

• Blood-brain barrier-penetrant FAK inhibitors

Cross-Links to Related CBS/PSP Mechanisms

• Tau Phosphorylation in CBS — Integrin-FAK signaling regulates GSK3β activity, a primary kinase in tau hyperphosphorylation

• Neuroinflammation in CBS — RAGE and integrin-mediated NF-κB activation drive inflammatory responses

• 4R Tauopathy Molecular Mechanisms — 4R tau isoform-specific interactions with integrin signaling

• Synaptic Dysfunction in CBS — Integrins at synaptic junctions regulate spine morphology

• Cellular Senescence in CBS — Integrin signaling alterations in senescent neurons and glia

• Extracellular Matrix Degeneration in Neurodegeneration — ECM remodeling in tauopathies

• Integrin Signaling in Parkinson’s Disease — Parallel mechanisms in synucleinopathies

• Focal Adhesion Kinase Pathway — Detailed FAK signaling cascade

• Extracellular Matrix in Neurodegeneration — General ECM biology